NCT07161388View on ClinicalTrials.gov

Durvalumab Consolidation After Chemoradiation Therapy for Limited Stage SCLC in China

Not yet recruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

October 15, 2025

Primary Completion Date

April 30, 2028

Study Completion Date

April 30, 2028

Conditions

Limited Stage Small-Cell Lung Cancer

Trial Locations (1)

250117

Cancer Hospital of Shandong First Medical University, Jinan

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY